Downregulation of IDH2 exacerbates H₂O₂-mediated cell death and hypertrophy

Area of Science:

• Cardiovascular Biology
• Mitochondrial Medicine
• Oxidative Stress Research

Background:

• Reactive oxygen species (ROS) contribute to cardiovascular disease pathophysiology.
• Mitochondrial NADP+-dependent isocitrate dehydrogenase (IDH2) acts as an antioxidant and anti-apoptotic protein by supplying NADPH.
• IDH2 supports cellular antioxidant systems.

Purpose of the Study:

• To investigate the role of IDH2 in protecting cardiomyocytes against oxidative stress.
• To determine the impact of IDH2 attenuation on hydrogen peroxide (H2O2)-induced cardiac cell damage.

Main Methods:

• Utilized small interfering RNA (siRNA) to specifically reduce IDH2 expression in H9c2 cardiomyoblasts.
• Induced apoptosis and hypertrophy using H2O2.
• Assessed cellular and mitochondrial redox status, mitochondrial function, and oxidative damage.
• Employed MitoTEMPO, a mitochondria-targeted antioxidant, for therapeutic assessment.

Main Results:

• siRNA-mediated IDH2 attenuation significantly exacerbated H2O2-induced apoptosis and hypertrophy in H9c2 cells.
• Reduced IDH2 expression altered cellular and mitochondrial redox balance and impaired mitochondrial function.
• MitoTEMPO treatment effectively mitigated increased caspase-3 activity, cell size, and glutathione (GSH) depletion in IDH2-deficient cells exposed to H2O2.

Conclusions:

• Disruption of cellular redox balance due to attenuated IDH2 expression is implicated in enhanced H2O2-induced apoptosis and hypertrophy.
• IDH2 plays a critical protective role against oxidative stress-induced cardiac cell damage.
• Targeting IDH2 or restoring redox balance may offer therapeutic strategies for cardiovascular diseases involving oxidative stress.